Implantable Device Discriminating Volemic States via Signal Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices lack the capability to reliably detect and distinguish between hypervolemia, hypovolemia, and euvolemia, which are critical fluid balance states in patients with heart failure, leading to inadequate management of fluid overload and potential complications.
Innovation Solution
An implantable medical device that analyzes time-domain and frequency-domain representations of cardiac pressure signals to discriminate between hypervolemia, hypovolemia, and euvolemia by assessing signal power distribution and shape characteristics, generating alerts and adjusting diuretic dosages accordingly.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cardiac pressure measurements are used to detect fluid overload, then detection capability is provided, but reliable discrimination between hypervolemia, hypovolemia and euvolemia is not achieved
Solution Approach 1:
The patent transitions from single-dimensional pressure measurement to multi-dimensional signal analysis by examining both time-domain characteristics (waveform shape, peak timing, area under curve) and frequency-domain characteristics (spectral content, power distribution). This dimensional expansion enables reliable discrimination between different volemic states that cannot be distinguished by pressure magnitude alone.
Solution Approach 2:
The patent analyzes multiple parameters derived from the pressure signal including time-domain features (peak timing, waveform shape, area under curve) and frequency-domain features (spectral power distribution, dominant frequencies). By monitoring changes in these parameters rather than relying on a single pressure threshold, the system achieves reliable discrimination between hypervolemia, hypovolemia and euvolemia.
2Reliability
If diuretics are administered to reduce thoracic fluids, then fluid overload is treated, but risk of causing hypovolemia increases
Solution Approach 1:
The patent implements continuous monitoring of pressure signal characteristics with real-time discrimination between volemic states. This feedback mechanism allows the system to detect euvolemia and adjust or stop diuretic administration, preventing overtreatment and hypovolemia. The closed-loop control ensures therapy is tailored to the patient's actual fluid status.
Solution Approach 2:
The system enables self-adjustment of diuretic therapy based on automated discrimination of volemic state. The device continuously assesses pressure signal characteristics and can trigger alerts or adjustments without requiring manual clinical assessment, allowing the treatment to self-regulate according to the patient's evolving fluid status.
3Reliability
If implantable devices are equipped with fluid detection capability, then management of fluid overload is improved, but device complexity increases
Solution Approach 1:
The patent leverages the existing implantable pressure sensor and signal processing capabilities to perform multiple functions: basic pressure monitoring, time-domain analysis, frequency-domain analysis, and discrimination between three volemic states. By making the device multi-functional, additional fluid management capability is added without requiring separate dedicated hardware systems.
Solution Approach 2:
The patent replaces complex mechanical fluid measurement systems with signal processing of existing pressure data. Instead of adding mechanical sensors or direct fluid volume measurement apparatus, the system uses computational analysis of pressure waveform characteristics to infer fluid status, substituting mechanical complexity with information processing.
Data Source
AI summary
Techniques are provided for use by an implantable medical device or diagnostic sensor for detecting and discriminating euvolemia, hypervolemia and hypovolemia. In one example, the device detects a pressure signal within the patient representative of changes in cardiac pressure overall several cardiac cycles. The device generates separate time-domain and frequency-domain representations of the pressure signal and then discriminates among euvolemia, hypervolemia and hypovolemia within the patient based on an analysis of the time-domain and the frequency-domain representations of the signal. Depending upon the capabilities of the device, suitable warnings may be generated to alert the patient or caregiver. Diuretics or other medications can be titrated to address abnormal fluid conditions such as a fluid overload during hypervolemia. Techniques for detecting a pressure alternans pattern indicative of imminent decompensation are also described.